Introduction
Methods
Design
Formation of the first draft of an early fluid resuscitation program for acute pancreatitis
Literature study
Semi-structured interviews
Delphi process
The expert panel
Characteristics | Round 1 (n = 15) n (%) | Round 2 (n = 14) n (%) |
---|---|---|
Sex | ||
Male | 10 (67) | 10 (71) |
Female | 5 (33) | 4 (29) |
Educational background | ||
Bachelor’s degree | 2 (13) | 1 (7) |
Master’s degree | 8 (53) | 8 (57) |
Doctoral degree | 5 (34) | 5 (36) |
Profession titles | ||
Senior | 2 (13) | 2 (14) |
Associate senior | 13 (87) | 12 (86) |
Professional experience (years) | ||
10-<20 | 12 (80) | 12 (86) |
20–30 | 3 (20) | 2 (14) |
Mentor type | ||
Master supervisor | 12 (80) | 11 (79) |
PhD supervisor | 3 (20) | 3 (21) |
Data collection
Data analysis
Ethical considerations
Results
Reliability judgment of the results of the expert correspondence
Degree of expert activism
Degree of expert authority
Degree of harmonization of expert advice
sports event | Number of indicators | Kendall’s harmony coefficient | chi-square (math.) | P value |
---|---|---|---|---|
First round (of match, or election) | ||||
Level 1 indicators | 4 | 0.335 | 15.092 | 0.002 |
Secondary indicators | 12 | 0.166 | 27.390 | 0.004 |
Tertiary indicators | 37 | 0.179 | 96.553 | < 0.0001 |
Second round (of match, or election) | ||||
Level 1 indicators | 5 | 0.364 | 20.379 | < 0.0001 |
Secondary indicators | 11 | 0.234 | 32.742 | < 0.0001 |
Tertiary indicators | 36 | 0.189 | 92.726 | < 0.0001 |
Results of the expert inquiry
Results of the first round of expert correspondence
Subjects | Mean ± SD | CV | Proportion scored ≥ 4 (%) |
---|---|---|---|
1 Admission assessment and disposition | 4.93 ± 0.26 | 0.05 | 100 |
1.1 Basic patient assessment | 4.33 ± 0.82 | 0.19 | 80 |
1.1.1 Time of onset | 4.53 ± 0.64 | 0.14 | 93 |
1.1.2 Causes | 4.27 ± 0.70 | 0.16 | 87 |
1.1.3 Weight | 4.80 ± 0.41 | 0.09 | 100 |
1.2 Assessment of the patient’s previous treatment | 4.00 ± 0.53 | 0.13 | 87 |
1.2.1 Diagnosis of AP with or without fluid replacement | 4.47 ± 0.74 | 0.17 | 87 |
1.2.2 When to start rehydration | 4.27 ± 0.88 | 0.21 | 80 |
1.2.3 Type, amount and rate of rehydrated fluid | 4.33 ± 0.82 | 0.19 | 80 |
1.3 Initial assessment of patient severity | 4.60 ± 0.63 | 0.14 | 93 |
1.3.1 Clinical assessment (age, comorbidities, hemodynamic status, urine output, etc.) | 4.60 ± 0.63 | 0.14 | 93 |
1.3.2 Use of the revised Atlanta classification | 4.33 ± 0.82 | 0.19 | 80 |
1.3.3 Laboratory tests (hematocrit, serum urea nitrogen, C-reactive protein level, lactate, etc.) | 4.53 ± 0.64 | 0.14 | 93 |
1.3.4 Define the criteria for determining hypovolaemia | 4.93 ± 0.26 | 0.05 | 100 |
1.4 Immediate disposal | 4.67 ± 0.62 | 0.13 | 93 |
1.4.1 Immediate initiation of early fluid resuscitation | 4.80 ± 0.41 | 0.09 | 100 |
1.4.2 Establish appropriate resuscitation access according to the patient’s condition and vascular conditions | 4.47 ± 0.52 | 0.12 | 100 |
2 Rehydration strategy | 4.47 ± 0.74 | 0.17 | 87 |
2.1 Types of rehydration | 4.27 ± 0.80 | 0.19 | 80 |
2.1.1 Preferred balanced saline solutions such as lactated Ringer’s solution for infusion | 4.60 ± 0.51 | 0.11 | 100 |
2.1.2 Artificial colloidal solutions such as hydroxyethyl are not recommended due to increased risk of organ failure | 4.20 ± 0.68 | 0.16 | 87 |
2.1.3 If pancreatitis is caused by hypercalcaemia, avoid calcium-containing Ringer’s solution | 4.13 ± 0.92 | 0.22 | 67 |
2.1.4 Colloidal preferential albumin, crystalloid/colloid = 3:1, fluid overload or tissue interstitial oedema, increase colloid ratio (1:1–2) | 3.87 ± 0.74 | 0.19 | 67 |
2.1.5 Principle: the order of rehydration is crystal first, then colloid, salt first, then sugar, see the urine to replenish potassium | 4.67 ± 0.62 | 0.13 | 93 |
2.2 Rate of rehydration | 4.53 ± 0.52 | 0.11 | 100 |
2.2.1 Failure to meet hypovolemic indicators, titrated at 2–3 mL/kg/h | 4.13 ± 0.74 | 0.18 | 80 |
2.2.2 Meet hypovolemic targets, titrate at 5–10 mL/kg/h and reduce fluid rate to 2–3 mL/kg/h when resuscitation targets are met | 4.40 ± 0.63 | 0.14 | 93 |
2.2.3 If refractory hypovolemic develops or resuscitation goals are not met at 12 h, reduce the fluid rate to 2–3mL/kg/h and notify the physician of relevant consultations | 4.53 ± 0.64 | 0.14 | 93 |
2.2.4 The presence of hypovolemic with complications of fluid overload should be treated according to the clinical judgement of the physician, and in difficult cases, relevant consultations will be held | 4.53 ± 0.64 | 0.14 | 93 |
2.2.5 Complications of fluid over-hydration, lowering or stopping fluid infusion, timely reporting to the doctor, and co-operating with the doctor in the use of diuretics and/or oxygen as required, as well as ECG, chest X-ray and blood gas analysis | 4.53 ± 0.64 | 0.14 | 93 |
2.3 Rehydration volume | 4.53 ± 0.64 | 0.14 | 93 |
2.3.1 Knowing that in most cases resuscitation goals can be met with 2.5 4 L of fluid in the first 24 h, but that some patients may need up to 5 L or more per day in the initial phase | 4.40 ± 0.85 | 0.21 | 86 |
2.3.2 If the amount of medically prescribed fluid is insufficient, ask the doctor promptly | 4.27 ± 0.59 | 0.14 | 93 |
2.3.3 Knowing that too much fluid may lead to multiple complications and strengthening monitoring | 4.33 ± 0.72 | 0.17 | 87 |
3 Rehydration monitoring | 4.40 ± 0.63 | 0.14 | 93 |
3.1 Monitoring projects | 4.33 ± 0.82 | 0.19 | 80 |
3.1.1 Vital signs, urine output | 4.87 ± 0.35 | 0.07 | 100 |
3.1.2 Blood tests (haematocrit, white blood cell count, urea nitrogen and creatinine, etc.) at 12 h (± 4), 24 h (± 4), 48 h (± 4) and 72 h (± 4) as required, and 4–6 h monitoring if on active fluid resuscitation | 4.67 ± 0.62 | 0.13 | 93 |
3.1.3 Depending on the patient’s condition, use ambulatory monitoring tools to guide fluid resuscitation if necessary, e.g. volume per beat (SV), volume per beat variability (SVV), pulse pressure variability (PPV) and cardiac ultrasound | 4.00 ± 0.65 | 0.16 | 80 |
3.1.4 In patients treated with insulin, especially in hypertriglyceridemic acute pancreatitis (HTG-AP), note the need for strict monitoring of blood glucose to keep it below 11.1 mmol/L, preferably at 6.1–8.3 mmol/L. | 4.33 ± 0.72 | 0.17 | 87 |
3.2 Importance of monitoring | 4.27 ± 0.80 | 0.19 | 80 |
3.2.1 Every 4–6 h, assess whether the patient has achieved 2 or more of the following resuscitation goals: heart rate < 120 beats/min, urine output > 0.5–1 ml-kg-1-h-1, mean arterial pressure 65–85 mmHg, hematocrit maintained at 35–44%, urea nitrogen < 7.14 mmol/L. | 4.67 ± 0.49 | 0.10 | 100 |
3.2.2 Focus on patient regression (number of hours patients reach resuscitation endpoints, proportion converted to SAP, mortality) | 4.00 ± 0.65 | 0.16 | 80 |
3.3 Vigilance against complications of fluid over-hydration | 4.53 ± 0.74 | 0.16 | 87 |
3.3.1 Observe for dyspnea, shortness of breath, chest congestion, shortness of breath, orthopnea, coughing up pink foamy sputum, etc. | 4.60 ± 0.74 | 0.16 | 87 |
3.3.2 Patients with SAP may have comorbid ACS and should be monitored for changes in intra-abdominal pressure and recorded | 4.47 ± 0.74 | 0.17 | 87 |
4 Health education | 4.07 ± 0.70 | 0.17 | 80 |
4.1 Knowledge of fluid resuscitation | 4.00 ± 0.65 | 0.16 | 80 |
4.1.1 Purpose of fluid resuscitation | 4.20 ± 0.77 | 0.18 | 80 |
4.1.2 Time required for fluid resuscitation | 4.20 ± 0.77 | 0.18 | 80 |
4.2 Matters requiring co-operation | 4.07 ± 0.59 | 0.15 | 87 |
4.2.1 No arbitrary adjustment of drip rate | 4.13 ± 0.74 | 0.18 | 80 |
4.2.2 Possible discomfort and countermeasures | 4.20 ± 0.77 | 0.18 | 80 |
Results of the second round of expert correspondence
Subjects | Mean ± SD | CV | Proportion scored ≥ 4 (%) |
---|---|---|---|
1 Initial in-hospital assessment | 4.93 ±0.27 | 0.05 | 100 |
1.1 Basic patient assessment | 4.57 ±0.65 | 0.14 | 93 |
1.1.1 Time of onset | 4.64 ±0.50 | 0.11 | 100 |
1.1.2 Medical history | 4.29 ±0.61 | 0.14 | 93 |
1.1.3 Weight/last weight of bedridden patient | 4.86 ±0.36 | 0.07 | 100 |
1.2 Assessment of the patient’s previous treatment | 4.21 ±0.58 | 0.14 | 93 |
1.2.1 Diagnosis of AP with or without fluid replacement | 4.57 ±0.65 | 0.14 | 93 |
1.2.2 Time to start rehydration | 4.43 ±0.76 | 0.17 | 86 |
1.2.3 Type and amount of fluid that has been rehydrated | 4.43 ±0.65 | 0.15 | 93 |
1.3 Initial assessment of patient severity | 4.86 ±0.36 | 0.07 | 100 |
1.3.1 Clinical assessment (age, comorbidities, hemodynamic status, urine output, etc.) | 4.71 ±0.47 | 0.10 | 100 |
1.3.2 Laboratory tests (hematocrit, serum urea nitrogen, C-reactive protein level, lactate, etc.) | 4.57 ±0.65 | 0.14 | 93 |
1.3.3 Identifying SSAP using BISAP scores | 4.50 ±0.65 | 0.14 | 93 |
1.3.4 Define the criteria for determining hypovolaemia | 4.93 ±0.27 | 0.05 | 100 |
2 Initial in-hospital intervention | 5.00 ±0.00 | 0.00 | 100 |
2.1 Timing of intervention and choice of access | 4.86 ±0.36 | 0.07 | 100 |
2.1.1 Immediate initiation of early fluid resuscitation | 4.93 ±0.27 | 0.05 | 100 |
2.1.2 Establish appropriate resuscitation access according to the patient’s condition and vascular conditions | 4.93 ±0.27 | 0.05 | 100 |
3 Rehydration strategies | 4.50 ±0.65 | 0.14 | 93 |
3.1 Types of rehydration | 4.43 ±0.65 | 0.15 | 93 |
3.1.1 Preferred balanced saline solutions such as lactated Ringer’s solution for infusion | 4.71 ±0.47 | 0.10 | 100 |
3.1.2 Artificial colloidal solutions such as hydroxyethyl are not recommended due to increased risk of organ failure | 4.36 ±0.50 | 0.11 | 100 |
3.1.3 Principle: the order of rehydration is crystal first, then colloid, salt first, then sugar, see the urine to replenish potassium | 4.79 ±0.43 | 0.09 | 100 |
3.2 Rate of rehydration | 4.64 ±0.50 | 0.11 | 100 |
3.2.1 Infusion at 2–3 mL/kg/h without hypovolemic indicators | 4.29 ±0.61 | 0.14 | 93 |
3.2.2 Meet hypovolemic targets and infuse at 5–10 mL/kg/h, reducing fluid rate to 2–3 mL/kg/h once resuscitation targets have been met | 4.57 ±0.51 | 0.11 | 100 |
3.2.3 If refractory hypotension occurs or resuscitation goals are not met at 6 h, notify the physician for relevant consultation | 4.45 ±0.65 | 0.15 | 93 |
3.2.4 The presence of hypovolaemia with the complication of fluid overload should be treated according to the physician’s clinical judgment and consultative opinion | 4.64 ±0.50 | 0.11 | 100 |
3.2.5 In the event of complications from over-hydration, reduce or stop the fluid infusion, report to the doctor promptly, and cooperate with treatment as required | 4.57 ±0.51 | 0.11 | 100 |
3.3 Rehydration volume | 4.50 ±0.65 | 0.14 | 93 |
3.3.1 In most cases, resuscitation goals are met with 2.5 4 L of fluid in the first 24 h, but some patients may require up to 5 L of fluid per day or more in the initial phase | 4.40 ±0.78 | 0.20 | 86 |
3.3.2 If the amount of medically prescribed fluid is insufficient, ask the doctor promptly | |||
3.3.3 Knowing that too much fluid may lead to multiple complications and strengthening monitoring | |||
4 Rehydration monitoring | 4.57 ±0.51 | 0.11 | 100 |
4.1 Effectiveness monitoring | 4.57 ±0.51 | 0.11 | 100 |
4.1.1 Vital signs, urine output | 4.79 ±0.43 | 0.09 | 100 |
4.1.2 Blood tests (hematocrit, white blood cell count, urea nitrogen and creatinine, etc.) at 12 h (± 4), 24 h (± 4), 48 h (± 4) and 72 h (± 4) as needed, and 4–6 h monitoring if on active fluid resuscitation | 4.64 ±0.63 | 0.14 | 93 |
4.1.3 Depending on the patient’s condition, use ambulatory monitoring tools to guide fluid resuscitation if necessary, e.g. volume per beat (SV), volume per beat variability (SVV), pulse pressure variability (PPV) and cardiac ultrasonography | 4.14 ±0.66 | 0.16 | 86 |
4.1.4 In patients treated with insulin, especially in hypertriglyceridemic acute pancreatitis (HTG-AP), note the need for strict monitoring of blood glucose to keep it below 11.1 mmol/L, preferably at 6.1–8.3 mmol/L. | 4.43 ±0.65 | 0.15 | 93 |
4.1.5 Every 4–6 h, assess whether the patient has achieved 2 or more of the following resuscitation goals: heart rate < 120 beats/min, urine output > 0.5–1 ml-kg–1-h-1, mean arterial pressure 65–85 mmHg, hematocritt maintained at 35–44%, urea nitrogen < 7.14 mmol/L | 4.86 ±0.36 | 0.07 | 100 |
4.1.6 Focus on patient regression (number of hours patients reach resuscitation endpoints, mortality) | 4.00 ±0.68 | 0.17 | 79 |
4.2 Complication monitoring | 4.57 ±0.65 | 0.14 | 93 |
4.2.1 Monitoring of CVP | 4.71 ±0.47 | 0.10 | 100 |
4.2.2 Observe for dyspnea, shortness of breath, chest congestion, shortness of breath, orthopnea, coughing up pink foamy sputum, etc. | 4.64 ±0.63 | 0.14 | 93 |
4.2.3 Patients with SAP may have comorbid ACS and should be monitored for changes in intra-abdominal pressure and recorded | 4.50 ±0.65 | 0.14 | 93 |
5 Health education | 4.21 ±0.58 | 0.14 | 93 |
5.1 Knowledge of fluid resuscitation | 4.14 ±0.53 | 0.13 | 93 |
5.1.1 Purpose of fluid resuscitation | 4.29 ±0.73 | 0.17 | 86 |
5.1.2 Time needed for fluid resuscitation | 4.36 ±0.63 | 0.15 | 93 |
5.2 Matters requiring co-operation | 4.14 ±0.53 | 0.13 | 93 |
5.2.1 No arbitrary adjustment of drip rate | 4.29 ±0.61 | 0.14 | 93 |
5.2.2 Possible discomfort and countermeasures | 4.36 ±0.63 | 0.15 | 93 |